Additional Information
Size: |
100 µl |
Target: |
LMR2 (pSer1450) |
Conjugate: |
ATTO 700 |
Research Area: |
Cancer | Cell Cycle | p53 Pathway | Cell Cycle Inhibitors| Cancer | Cancer Metabolism | Cell Signaling | Metabolism | Energy Transfer Pathways |
Alternative Name: |
AATYK 2 antibody, Apoptosis associated tyrosine kinase 2 antibody, Apoptosis-associated tyrosine kinase 2 antibody, Brain enriched kinase antibody, BREK antibody, CDK5/p35 regulated kinase antibody, Kinase phosphatase inhibitor 2 antibody, KPI 2 anti |
Category: |
Antibodies |
Product Type: |
Polyclonal Antibody |
Immunogen: |
A phospho-specific peptide corresponding to residues surrounding Ser1450 of human LMR2 (AA1447-1453) |
Immunogen Species: |
Human |
Applications: |
WB, AM |
Host: |
Rabbit |
Isotype: |
N/A |
Species Reactivity: |
Human |
Antibody Dilution: |
WB (1:250); optimal dilutions for assays should be determined by the user. |
Purification: |
Peptide Affinity Purified |
Storage Buffer: |
PBS pH7.4, 50% glycerol, 0.025% Thimerosal |
Concentration: |
N/A |
Specificity: |
Detects 164.9 kDa. |
Storage: |
-20ºC |
Shipping: |
Blue Ice or 4ºC |
Certificate of Analysis: |
A 1:250 dilution of SPC-1010 was sufficient for detection of LMR2 (pSer1450) in 10 µg of HeLa cell lysate by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody. |
Cellular Localization: |
Membrane |
Tissue Specificity: |
Mainly expressed in skeletal muscle, and weakly in brain and pancreas. |
Accession Number: |
NP_055731 |
Gene ID: |
22853 |
Swiss-Prot: |
Q8IWU2 |
Field of Use: |
For in vitro research use only. |